$ANNX 3 SEC Filings

Filed On	Filing
12 Aug 2026	Form 3: Blumenkranz Mark S., Director No securities owned
10 Jan 2025	Form 3: Jones William A Jr, Director No securities owned
02 Aug 2023	Form 3: Dananberg Jamie, Chief Medical Officer No securities owned
30 May 2023	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 3 others Holds 5,401,926 shares of Common Stock
27 Mar 2023	Form 3: Yednock Ted, EVP & Chief Innovation Officer Holds 38,942 shares of Common Stock
12 Jan 2023	Form 3: Artis Dean Richard, EVP & Chief Scientific Officer Holds 50,329 shares of Common Stock
20 Jan 2022	Form 3: Cockroft Bettina M., Director No securities owned
04 Oct 2021	Form 3: Mattheakis Larry, Chief Scientific Officer No securities owned
16 Aug 2021	Form 3: Waddill William D., Director No securities owned
08 Feb 2021	Form 3: Carson William H., Director No securities owned
23 Jul 2020	Form 3: Flynn James E, 10% owner and 5 others
23 Jul 2020	Form 3: Clarus Lifesciences III, L.p., 10% owner and 7 others
23 Jul 2020	Form 3: Sonsini Peter W., 10% owner
23 Jul 2020	Form 3: Sandell Scott D, 10% owner
23 Jul 2020	Form 3: Makower Joshua, 10% owner
23 Jul 2020	Form 3: Makhzoumi Mohamad, 10% owner
23 Jul 2020	Form 3: Florence Anthony A. Jr., 10% owner
23 Jul 2020	Form 3: Baskett Forest, 10% owner
23 Jul 2020	Form 3: Gallagher Carol Giltner, Director No securities owned
23 Jul 2020	Form 3: New Enterprise Associates 15, L.p., 10% owner and 2 others

Comments